Thursday, November 20, 2008 - 6:55PM EST

Review Articles

51. Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a systematic review.

Author
Feld R; Sridhar SS; Shepherd FA; Mackay JA; Evans WK;
Institution
Princess Margaret Hospital, Toronto, Ontario, Canada.
Journal
J Thorac Oncol. 2006 May;1(4):367-76.
Abstract URL
Click here to view abstract

52. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.

Author
Wakelee H; Dubey S; Gandara D;
Institution
Oncology, Stanford University, 875 Blake Wilbur Drive, Room 2233, Stanford, California 94305-5826, USA. hwakelee@stanford.edu
Journal
Oncologist. 2007 Mar;12(3):331-7.
Abstract URL
Click here to view abstract

53. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: A systematic review and metaanalysis.

Author
Micames CG; McCrory DC; Pavey DA; Jowell PS; Gress FG; Micames CG; McCrory DC; Pavey DA; Jowell PS; Gress FG;
Institution
Duke University Medical Center, Division of Gastroenterology, Box 3913, Durham, NC 27710, USA. Carlos.micames@duke.edu
Journal
Chest. 2007 Feb;131(2):539-48.
Abstract URL
Click here to view abstract

54. Lung cancer.

Author
Ginsberg MS; Grewal RK; Heelan RT; Ginsberg MS; Grewal RK; Heelan RT;
Institution
Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. ginsberm@mskcc.org
Journal
Radiol Clin North Am. 2007 Jan;45(1):21-43.
Abstract URL
Click here to view abstract

55. Innovations in the radiotherapy of non-small cell lung cancer.

Author
Schild SE; Bogart JA;
Institution
North Central Cancer Treatment Group Lung Committee and Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona 85259, USA. sschild@mayo.edu
Journal
J Thorac Oncol. 2006 Jan;1(1):85-92.
Abstract URL
Click here to view abstract

56. Second- and third-line treatments in non-small cell lung cancer.

Author
Kumar A; Wakelee H;
Institution
Stanford Cancer Center, Stanford, CA 94305, USA. hwakelee@stanford.edu
Journal
Curr Treat Options Oncol. 2006 Jan;7(1):37-49.
Abstract URL
Click here to view abstract

57. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience.

Author
Takeda S; Maeda H; Koma M; Matsubara Y; Sawabata N; Inoue M; Tokunaga T; Ohta M;
Institution
Department of General Thoracic Surgery, National Hospital Organization, Toneyama National Hospital, Toneyama 5-1-1, Toyonaka, Osaka 560-8552, Japan. stakeda@toneyama.hosp.go.jp
Journal
Eur J Cardiothorac Surg. 2006 Mar;29(3):276-80. Epub 2006 Jan 24.
Abstract URL
Click here to view abstract

58. Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer.

Author
Fuentes R; Bonfill X; Exposito J;
Institution
Institut Catala d'Oncologia, Avda Franca, s/n, Girona, Spain, 17007. rfuentes@ico.scs.es
Journal
Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004840.
Abstract URL
Click here to view abstract

59. Gemcitabine and carboplatin: is this the best combination for non-small cell lung cancer?

Author
Saha A; Rudd R;
Institution
Medical Oncology, St Bartholomew's Hospital, London, UK. antonio.saha@cancer.org.uk
Journal
Expert Rev Anticancer Ther. 2006 Feb;6(2):165-73.
Abstract URL
Click here to view abstract

60. Second-line treatment options in advanced non-small cell lung cancer: current status.

Author
Cullen M;
Institution
Cancer Centre, University Hospital Birmingham, Birmingham, UK. michael.cullen@uhb.nhs.uk
Journal
Semin Oncol. 2006 Feb;33(1 Suppl 1):S3-8.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9